This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Cardinal Health to Pay $44M as Civil Penalty Settlement
by Zacks Equity Research
Cardinal Health Inc. (CAH) announced that it would shell out $44 million as civil penalties for a 2012 administrative settlement with the U.S. Drug Enforcement Agency or DEA.
Varian to Acquire PerkinElmer's Medical Imaging Business
by Zacks Equity Research
Varian Medical Systems, Inc. (VAR) recently announced an agreement to takeover the Medical Imaging business of Waltham, MA-based PerkinElmer, Inc. (PKI) for $276 million.
DaVita Ties Up With WellHealth, Expands in Southern Nevada
by Zacks Equity Research
DaVita HealthCare Partners Inc. (DVA), a leading provider of dialysis services, announced that HealthCare Partners Nevada, a unit within its medical group, has acquired WellHealth Quality Care.
Fluidigm Unveils High-Throughput Integrated Fluidic Circuit
by Zacks Equity Research
Fluidigm Corporation (FLDM), a leading player in the analysis of single cells and industrial application of genomics, recently unveiled a new high-throughput integrated fluidic circuit (HT IFC) to separate single cells during mRNA sequencing analysis.
WebMD Health (WBMD) Repurchaces 2 Million Common Shares
by Zacks Equity Research
WebMD Health Corp. (WBMD) announced that it has completed a tender offer to purchase 2 million shares of its common stock.
Accuray: Hong Kong Sanatorium to Buy 3 Radixact Systems
by Zacks Equity Research
Accuray Incorporated (ARAY) has signed an agreement with Hong Kong Sanatorium & Hospital per which the latter would purchase three Radixact Systems.
Meridian Bioscience Partners MedCaptain, Expands in China
by Zacks Equity Research
Meridian Bioscience, Inc. (VIVO) announced that its Magellan Diagnostics business has signed a distribution agreement with China-based MedCaptain Medical Technology.
DexCom (DXCM) Gains FDA Approval for G5 Mobile CGM System
by Zacks Equity Research
San Diego, CA-based DexCom, Inc. (DXCM), a renowned medical device company, announced the U.S. FDA approval for its G5 Mobile CGM (continuous glucose monitoring) system.
Luminex Awarded R&D 100 for ARIES Systems in November
by Zacks Equity Research
Luminex Corporation (LMNX) announced that its ARIES Systems was awarded the R&D 100 Award at the 54th Annual R&D 100 Awards ceremony in November.
Allscripts Buys Core Medical Solutions, Expands in Australia
by Zacks Equity Research
Allscripts Healthcare Solutions, Inc. (MDRX), a leading global provider of information technology and services to healthcare organizations, recently announced the acquisition of Core Medical Solutions to expand its offerings in Australia.
Envision Healthcare Ties Up with Alabama Neonatal Medicine
by Zacks Equity Research
Envision Healthcare Corporation (EVHC) announced the acquisition of Alabama Neonatal Medicine, P.C. and the extension of its Women's and Children's Services specialty.
Neogen (NEOG) to Buy Quat-Chem, Shares Hit 52-Week High
by Zacks Equity Research
Neogen Corporation (NEOG), recently announced the acquisition of United Kingdom-based Quat-Chem Ltd., a chemical company which develops, manufactures and sells agricultural, industrial, and food processing biocidal hygiene products.
Varian (VAR) in Just 100 List from JUST Capital and Forbes
by Zacks Equity Research
Varian Medical Systems Inc. (VAR) announced it was included in the inaugural JUST 100 List.
Veeva Systems Set to Grow on Subscription Revenue Focus
by Zacks Equity Research
On Nov 30, we issued an updated research report on Pleasanton, CA-based Veeva Systems Inc. (VEEV).
TrovaGene Inks Contract with Boreal Genomics, Stock Down
by Zacks Equity Research
TrovaGene Inc. (TROV), a molecular diagnostic company, recently announced the signing of a long-term Supply and Distribution Agreement with Boreal Genomics.
Patterson Companies: Q2 Results Dismal, Forex a Concern
by Zacks Equity Research
On Nov 30, we issued an updated research report on St. Paul, MN-based Patterson Companies Inc. (PDCO) ??? a leading distributor of dental and animal health products.
Evolent Health (EVH) Prices $110M Convertible Senior Notes
by Zacks Equity Research
Evolent Health, Inc. (EVH), announced the pricing of $110.0 million worth senior notes.
Cynosure (CYNO) Gets CFDA Approval to Market Icon System
by Zacks Equity Research
Cynosure, Inc. (CYNO) announced that it has received clearance from the China Food and Drug Administration (CFDA) to market the Icon Aesthetic System.
Baxter (BAX) Inks Partnership with Americares, Stock Down
by Zacks Equity Research
Baxter International Inc. (BAX) announced a new oral health project in collaboration with Americares, a health-focused relief and development organization.
Varian & Komazawa Establish Radiotherapy Education Center
by Zacks Equity Research
Varian Medical Systems Inc. (VAR) announced a partnership with Komazawa University in Japan to establish an advanced radiotherapy education center equipped with a fully functional Varian TrueBeam medical linear accelerator.